AU2002225714A1 - Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage - Google Patents

Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage

Info

Publication number
AU2002225714A1
AU2002225714A1 AU2002225714A AU2571402A AU2002225714A1 AU 2002225714 A1 AU2002225714 A1 AU 2002225714A1 AU 2002225714 A AU2002225714 A AU 2002225714A AU 2571402 A AU2571402 A AU 2571402A AU 2002225714 A1 AU2002225714 A1 AU 2002225714A1
Authority
AU
Australia
Prior art keywords
cartilage
cytokines
receptor
bone
modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002225714A
Inventor
Dominik Haudenschild
Timothy Moseley
A. Hari Reddi
Larry Rose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2002225714A1 publication Critical patent/AU2002225714A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2002225714A 2000-11-10 2001-11-13 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage Abandoned AU2002225714A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US24713400P 2000-11-10 2000-11-10
US60/247,134 2000-11-10
US27119701P 2001-02-23 2001-02-23
US60/271,197 2001-02-23
US32890401P 2001-10-12 2001-10-12
US60/328,904 2001-10-12
PCT/US2001/043855 WO2002038764A2 (en) 2000-11-10 2001-11-13 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage

Publications (1)

Publication Number Publication Date
AU2002225714A1 true AU2002225714A1 (en) 2002-05-21

Family

ID=27400009

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002225714A Abandoned AU2002225714A1 (en) 2000-11-10 2001-11-13 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage

Country Status (3)

Country Link
US (1) US20040171109A1 (en)
AU (1) AU2002225714A1 (en)
WO (1) WO2002038764A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2500921T3 (en) 2003-04-29 2014-10-01 Sarepta Therapeutics, Inc. Compositions to enhance the transport and antisense efficacy of nucleic acid analogs in cells
US20050288246A1 (en) 2004-05-24 2005-12-29 Iversen Patrick L Peptide conjugated, inosine-substituted antisense oligomer compound and method
CA2569867A1 (en) 2004-06-10 2005-12-29 Zymogenetics, Inc. Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation
US8067571B2 (en) 2005-07-13 2011-11-29 Avi Biopharma, Inc. Antibacterial antisense oligonucleotide and method
US20070249533A1 (en) 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same
WO2007071439A1 (en) * 2005-12-22 2007-06-28 Laboratoires Serono S.A. Soluble il-17rc variant and uses thereof
ES2347840T3 (en) * 2006-02-10 2010-11-04 Zymogenetics, Inc. IL-17RCX4 SOLUBLE AND PROCEDURE FOR USE IN INFLAMMATION.
MX2009009167A (en) 2007-02-28 2009-09-04 Schering Corp Combination therapy for treatment of immune disorders.
US7790676B2 (en) 2007-03-28 2010-09-07 Zymogenetics, Inc. Soluble IL-17RA/RC fusion proteins
US20100239590A1 (en) * 2007-06-20 2010-09-23 Schering Corporation Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
US20100016215A1 (en) 2007-06-29 2010-01-21 Avi Biopharma, Inc. Compound and method for treating myotonic dystrophy
US20090136465A1 (en) 2007-09-28 2009-05-28 Intrexon Corporation Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
US8324165B2 (en) 2008-05-14 2012-12-04 Five Prime Therapeutics, Inc. Compositions for treating arthritis comprising HG1023575 polypeptide
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
CA3090304A1 (en) * 2010-05-13 2011-11-17 Sarepta Therapeutics, Inc. Antisense modulation of interleukins 17 and 23 signaling
US9161948B2 (en) 2011-05-05 2015-10-20 Sarepta Therapeutics, Inc. Peptide oligonucleotide conjugates
WO2016196897A1 (en) 2015-06-04 2016-12-08 Sarepta Therapeutics, Inc. Methods and compounds for treatment of lymphocyte-related diseases and conditions
EP3452598A4 (en) 2016-05-06 2020-04-29 Exicure, Inc. Liposomal spherical nucleic acid (sna) constructs presenting antisense oligonucleotides (aso) for specific knockdown of interleukin 17 receptor mrna
RS63610B1 (en) 2016-12-19 2022-10-31 Sarepta Therapeutics Inc Exon skipping oligomer conjugates for muscular dystrophy
US11696954B2 (en) 2017-04-28 2023-07-11 Exicure Operating Company Synthesis of spherical nucleic acids using lipophilic moieties

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0817847T4 (en) * 1995-03-23 2009-10-05 Immunex Corp IL-17 receptor
WO1999058660A1 (en) * 1998-05-12 1999-11-18 Human Genome Sciences, Inc. 97 human secreted proteins
US20020177188A1 (en) * 1998-05-15 2002-11-28 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6569645B2 (en) * 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
US6207462B1 (en) * 1998-03-20 2001-03-27 Cem Corporation Microwave apparatus and method for analysis of asphalt-aggregate compositions
PT1076703E (en) * 1998-05-15 2007-10-10 Genentech Inc Therapeutic uses of il-17 homologous polypeptides
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
AU6069800A (en) * 1999-07-07 2001-01-30 Zymogenetics Inc. Human cytokine receptor
EP1067182A3 (en) * 1999-07-08 2001-11-21 Helix Research Institute Secretory protein or membrane protein
CA2380355A1 (en) * 1999-09-01 2001-03-08 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ES2380812T3 (en) * 1999-12-23 2012-05-18 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
AU2001260847A1 (en) * 2000-05-24 2001-12-03 Genesis Research And Development Corporation Limited Compositions isolated from skin cells and methods for their use
US20030092881A1 (en) * 2000-05-24 2003-05-15 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods
AU2001271860A1 (en) * 2000-07-06 2002-01-21 Zymogenetics Inc. Murine cytokine receptor

Also Published As

Publication number Publication date
WO2002038764A3 (en) 2003-07-10
WO2002038764A2 (en) 2002-05-16
US20040171109A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
AU2002225714A1 (en) Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
AU2002337953A1 (en) Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
AU2001275860A1 (en) Surgical prep solution applicator system and methods
AU2002314466A1 (en) Withasol and methods of use
AU2002322558A1 (en) Device for regeneration of articular cartilage and other tissue
AU2001274817A1 (en) Agents that modulate dna-pk activity and methods of use thereof
AU2002305552A1 (en) Arylsulfonamide ethers, and methods of use thereof
AU2001285302A1 (en) Antisense modulation of ubiquitin protein ligase expression
AU2002233608A1 (en) Modulation of gsk-3beta activity and its different uses
AU2002216245A1 (en) Methods of modulating toll-related receptor (trr) signaling
AU2001297556A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
AU2002235202A1 (en) Treatment of bone disorders by modulation of fgfr3
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2002241570A1 (en) Human proteins, polynucleotides encoding them and methods of using the same
AU2001268361A1 (en) Method of modulating expression of ldl-receptor-related protein and uses thereof
AU2001297794A1 (en) Methods and compositions of human proteins and uses thereof.
AU2002314732A1 (en) Modulators of leukocyte activation, compositions and methods of use
AU2002225852A1 (en) "67118", "67067" and "62092", human proteins and methods of use thereof
AU2002245158A1 (en) Human proteins 55562 and 21617, and methods of use thereof
AU2002245505A1 (en) Non-racemic hexafluoreleucine, and methods of making and using it
WO2002079390A9 (en) $i(pesudomonas) avr and hop proteins, their encoding nucleic acids, and use thereof
AU2001236907A1 (en) Human protein tyrosine phosphatase, encoding dna and uses thereof
AU2001264869A1 (en) Human secreted protein, zsig47
AU2001230560A1 (en) Novel gene tig104alpha and protein tig104alpha encoded thereby
AU2001273447A1 (en) Tetraspan protein and uses thereof